ID   MCS-2 [Human breast carcinoma]
AC   CVCL_R955
DR   BTO; BTO:0002271
DR   cancercelllines; CVCL_R955
DR   Wikidata; Q54904534
RX   PubMed=14623544;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Transfected with: HGNC; 11425; STS.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 17
//
RX   PubMed=14623544; DOI=10.1016/S0960-0760(03)00357-1;
RA   Nakata T., Takashima S., Shiotsu Y., Murakata C., Ishida H.,
RA   Akinaga S., Li P.-K., Sasano H., Suzuki T., Saeki T.;
RT   "Role of steroid sulfatase in local formation of estrogen in
RT   post-menopausal breast cancer patients.";
RL   J. Steroid Biochem. Mol. Biol. 86:455-460(2003).
//